Home › Pulmonary Hypertension › Arizona
Pulmonary Hypertension clinical trials in Arizona
10 studies for Pulmonary Hypertension are looking for participants at sites in Arizona.
Cities in Arizona
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Banner - University Medical Center Tucson, Tucson
Recruiting
Ages 18 to 85 · All sexes · Updated Oct 1, 2026 · NCT07214376Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA027, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07179380Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Phoenix, Phoenix
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 8, 2026 · NCT07473700Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Banner University Medical Center, Phoenix
- Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
- Arizona Pulmonary Specialists, Ltd., Scottsdale
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Banner Health - University Medical Center Phoenix, Phoenix
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Arizona Pulmonary Specialists, Phoenix
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Arizona Pulmonary Specialists, Phoenix
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Jun 26, 2026 · NCT06129240Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Banner-University Medical Center Phoenix, Phoenix
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195Pulmonary Hypertension Association Registry
- Arizona Pulmonary Specialists, Ltd., Phoenix
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.